RV41 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fennec Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 9.15 EUR -0.54% Market Closed

Market Cap: €250m

F	Fennec Pharmaceuticals Inc F:RV41	US
C	CDW Corp DUS:CDW	US
W	Westport Fuel Systems Inc F:WPIA	CA
	Springfield Properties PLC F:9MZ	UK
C	China Construction Bank Corp F:C6T	CN

Profitability Summary

Fennec Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

93%

Declining Gross Margin

95% > 92%

Negative Operating Margin

-14%

Negative 3Y Average Operating Margin

-56%

Operating Margin is Increasing

-366% > -14%

Negative Net Margin

-22%

Negative 3Y Average Net Margin

-68%

Net Margin is Increasing

-404% > -22%

Negative Free Cash Flow Margin

-28%

Negative 3Y Average Free Cash Flow Margin

-43%

Free Cash Flow Margin is Increasing

-326% > -28%

Negative ROE

-66%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1 327%

ROIC is Increasing

-12 621% > -29%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.